Clinical Trials on Obesity, Morbid in Australia

Total 163 results

University of Sydney

Active, not recruiting

Sub-Study of the PREVIEW Study Australia

Obesity | Pre-diabetes

Australia
Garvan Institute of Medical Research

Completed

Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome

Prader-Willi Syndrome

Australia
Medical University of Vienna

Completed

Impact of Calory Restriction and Biofeedback on Endocrine and Mental Health

Obesity | Psychological | Mental Stress | Neuroendocrinology

Austria
Murdoch Childrens Research Institute
National Health and Medical Research Council, Australia; Royal Children's Hospital and other collaborators

Recruiting

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents (GenV)

Communicable Diseases | Quality of Life | Inflammation | Obesity | Congenital Abnormalities | Genetics | Healthy Aging | Child Development | Diet | Mental Health | Disability | Injuries | Cognition | Child Health | Environmental Exposure | Noncommunicable Diseases | Physical Fitness | Intergenerational Relations | Social Determinants... and other conditions

Australia
Medical University of Graz

Completed

EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes

Austria
Eli Lilly and Company
Versanis Bio, Inc.

Active, not recruiting

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

Obesity | Obese | Overweight or Obesity

United States, Australia, New Zealand
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens) (ACTION Teens)

Obesity

Spain, Turkey, Italy, Taiwan, Australia, Colombia, Korea, Republic of, Mexico, Saudi Arabia, United Kingdom
Medical University of Graz

Completed

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines (TNF4)

Obesity | Type 2 Diabetes Mellitus

Austria
Mount Sinai Hospital, Canada
Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute

Recruiting

The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial (MiTy Tykes)

Diabetes Mellitus, Type 2 | Child Development | Child Obesity | Pregnancy in Diabetic

Canada, Australia
ReShape Lifesciences

Unknown

The Safety and Efficacy of vBloc Therapy Delivered by the Maestro Rechargeable System for the Treatment of Obesity (ReCharge)

Obesity

United States, Australia
Novo Nordisk A/S

Recruiting

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

Obesity

United States, Australia, Japan
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management - An International Observation (ACTION-IO)

Obesity

United Arab Emirates, Australia, Israel, Korea, Republic of, Mexico, Saudi Arabia, Spain, Switzerland, United Kingdom
Zafgen, Inc.

Completed

Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus | Overweight and Obesity

Australia, New Zealand
Medical University of Graz
Technical University of Munich; Paracelsus Medical University; University of... and other collaborators

Recruiting

Observational Study of Early Metabolic and Vascular Changes in Obesity (STYJOBS)

Inflammation | Obesity | Atherosclerosis | Fatty Liver | Adiponectin Deficiency

Austria
Anne Birgitte Raben
University of Nottingham; University of Helsinki; Wageningen University; University... and other collaborators

Completed

Effect of Diet and Physical Activity on Incidence of Type 2 Diabetes (PREVIEW)

Obesity | Pre-diabetes

Spain, Denmark, Australia, Bulgaria, Finland, Netherlands, New Zealand, United Kingdom
Medical University of Graz

Completed

Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes (PROLOG)

Healthy | Obesity | Type 2 Diabetes Mellitus | Type 1 Diabetes

Austria
Medical University of Graz

Recruiting

ESAN II - Energy Sensing in Depression

Depression | Obesity | Microbial Colonization | Diet, Healthy | Immune System Tolerance

Austria
Sanofi

Completed

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients (ADAGIO-lipids)

Obesity | Dyslipidemia

United States, Canada, Brazil, Australia, Italy, Sweden, Malaysia, Singapore, Taiwan, Mexico, Denmark, Korea, Republic of, Hong Kong, South Africa
Boehringer Ingelheim

Completed

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

Obesity

Belgium, Australia, Sweden, United States, Canada, Germany, Korea, Republic of, China, Netherlands, New Zealand, United Kingdom, Poland
University Hospital Tuebingen
Medical University of Vienna; University of Bern; CenTrial GmbH

Terminated

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

Obesity | Diabetes

Austria, Germany, Switzerland
Pfizer

Terminated

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Obesity

United States, Australia, Canada, Brazil, Slovakia, Czech Republic, Argentina, Germany, Mexico, United Kingdom, Sweden
Alexandra Kautzky-Willer
Bayer

Recruiting

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism (Test2Func)

Fatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes Mellitus

Austria
Medical University of Vienna

Completed

Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Epistaxis | HHT | Morbus Osler

Austria
Zafgen, Inc.

Completed

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury

Obesity | Craniopharyngioma | Over-weight | Hypothalamic Injury

United States, Australia
Sanofi

Terminated

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose (PRADO)

Obesity

France, Canada, Brazil, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Bulgaria, Slovakia, Belgium, Czech Republic, Austria, Denmark, Egypt, Finland, Greece, Hungary, Ireland, Israel, Italy, Lithuania, Luxembourg, Mexico, Norway, United Kingdom
Department of Nephrology Clinic Ottakring Vienna

Recruiting

Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study

Diabetes Mellitus | Chronic Kidney Diseases | PreDiabetes | Overweight and Obesity

Austria
Pfizer

Terminated

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

Obesity

Australia, United States, Korea, Republic of, Spain, France, United Kingdom, Germany, Sweden, Argentina, Chile, Mexico
Novo Nordisk A/S

Completed

Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (STEP-HFpEF)

Obesity

United States, Israel, United Kingdom, Denmark, Germany, Netherlands, Canada, Argentina, Czechia, Hungary, Poland, Spain, Australia
VASCage GmbH
Medical University Innsbruck; Tirol Kiniken GmbH

Completed

Early Vascular Ageing in the YOUth (EVA4YOU)

Cardiovascular Diseases | Vascular Diseases | Hypertension | Obesity | Overweight | Sleep Disorder | Atherosclerosis | Sleep | Headache | Vascular Stiffness | Cardiovascular Risk Factor | Non-Alcoholic Fatty Liver Disease | Life Style | Cardiovascular Pathology

Austria
Eli Lilly and Company

Recruiting

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)

Cardiovascular Diseases | Obesity

United States, Australia, Mexico, Spain, Canada, Hungary, Argentina, Puerto Rico, Poland, Slovakia
Sanofi

Completed

Obese Patients With Untreated Dyslipidemias (RIO-Lipids)

Obesity | Dyslipidemia

United States, Canada, Australia, Italy, Spain, Sweden, Switzerland, Finland
German Federal Institute for Risk Assessment
University of Vienna; Heidelberg University; University of Jena; University of... and other collaborators

Not yet recruiting

Cohort Study on Plant-based Diets (COPLANT Study) (COPLANT)

Cardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Bone Loss | Dietary Exposure | Sustainability | Vitamin Deficiency | Mineral Deficiency | Exposure

Germany, Austria
Eli Lilly and Company

Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Overweight and Obesity

United States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
Novo Nordisk A/S

Recruiting

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial (SELECT-LIFE)

Obesity | Overweight

Brazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
Children's & Women's Health Centre of British Columbia

Unknown

Testing the Developmental Origins Hypothesis (CHIPS-Child)

Stroke | Obesity | Diabetes

Netherlands, United States, United Kingdom, Canada, Chile, Australia, Estonia, New Zealand
Novo Nordisk A/S

Completed

A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

Obesity | Overweight

United States, Croatia, Russian Federation, United Kingdom, Belgium, Mexico, Austria, Ireland
Novo Nordisk A/S

Recruiting

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight (STEP Young)

Obesity

Belgium, United Kingdom, Denmark, United States, Sweden, Portugal, Austria, Germany, Israel, Mexico
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults

Obesity | Overweight

Austria, United Kingdom, United States, Slovakia, Hungary, Czechia, Canada
Boehringer Ingelheim

Active, not recruiting

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight (SYNCHRONIZE™-1)

Obesity

United States, Korea, Republic of, Belgium, Australia, China, Poland, Japan, Finland, Germany, Canada, Netherlands, New Zealand, Sweden, United Kingdom
Eli Lilly and Company

Recruiting

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee (TRIUMPH-4)

Obesity | Overweight | Osteo Arthritis Knee

United States, Canada, Spain, Australia, Mexico, United Kingdom
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

Obesity | Overweight

Spain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
Novo Nordisk A/S

Active, not recruiting

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight (REDEFINE 1)

Obesity

Finland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
Amgen

Active, not recruiting

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

Obesity | Overweight | Type 2 Diabetes Mellitus

United States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
Novo Nordisk A/S

Completed

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT)

Obesity | Overweight

United States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
Boehringer Ingelheim

Recruiting

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Obesity

United States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
Novo Nordisk A/S

Recruiting

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels (REDEFINE 3)

Cardiovascular Disease

Netherlands, Australia, Italy, United States, Serbia, Spain, United Kingdom, Thailand, India, Malaysia, Turkey, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
Novo Nordisk A/S

Completed

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

Obesity | Metabolism and Nutrition Disorder

United States, Israel, Russian Federation, United Kingdom, Canada, Belgium, Germany, Australia
Novo Nordisk A/S

Completed

Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome

Obesity | Metabolism and Nutrition Disorder

France, United States, Turkey, Italy, Australia, New Zealand, Canada, Netherlands
Levo Therapeutics, Inc.

Completed

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome (CARE-PWS)

Prader-Willi Syndrome

United States, Canada, Australia
Boehringer Ingelheim

Recruiting

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

Obesity | Diabetes Mellitus, Type 2

United States, Korea, Republic of, Australia, Spain, Belgium, China, Hungary, Canada, United Kingdom, Japan, Czechia, Poland, Greece, New Zealand, Denmark, Finland, Germany, Netherlands, Sweden

Clinical Trials on Obesity, Morbid in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations